Cara Therapeutics Inc.

4.94
-0.13 (-2.56%)
At close: Apr 01, 2025, 3:31 PM
4.93
-0.20%
After-hours: Apr 01, 2025, 06:43 PM EDT

Cara Therapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
PE Ratio -3.94 -4.08 -82.9 -84.05 1.02K -77.55 -75.65 -78.85 -53.09 -201.75
PEG Ratio 0.13 -0.1 7.59 0.08 -9.55 -3.72 -7.04 6.90 -0.48 -11.43
PS Ratio 39.13 23.04 165.16 321.91 63.73 414.81 415.72 5.03K 35.36K 1.31K
PB Ratio -60.8 8.46 43.55 32.58 34.57 44.18 41.90 52.81 59.95 47.42
P/FCF Ratio -4.51 -5.11 -87.78 -123.29 -1.48K -75.51 -250.26 -83.5 -63.22 -231.7
P/OCF Ratio -4.58 -5.25 -87.83 -123.37 -1.57K -75.52 -251.08 -83.59 -64.18 -231.92
OCF/S Ratio -8.54 -4.39 -1.88 -2.61 -0.04 -5.49 -1.66 -60.18 -550.94 -5.65
Debt / Equity Ratio n/a 0.76 0.01 0.02 0.02 0.02 n/a n/a n/a n/a
Quick Ratio 10.81 4.43 7.10 9.69 10.64 3.88 4.16 11.18 5.33 20.68
Current Ratio 11.03 4.54 7.20 9.84 10.55 3.86 4.16 11.18 5.33 20.68
Asset Turnover 0.16 0.17 0.23 0.09 0.50 0.09 0.07 0.01 0.00 0.03
Interest Coverage -6.89 -201.15 n/a n/a n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Return on Assets (ROA) n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Return on Capital (ROIC) n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% 70.56% 82.65% 93.25% 20.74% -4.69% -4.61% -52.26% -571.71% -4.58%
Net Profit Margin -992.95% -565.21% -199.23% -382.98% 6.23% -5.35% -5.5% -63.8% -666.05% -6.49%
Pretax Profit Margin -998.53% -565.21% -204.16% -384.06% 5.71% -5.39% -5.52% -64.03% -671.49% -6.6%
Operating Profit Margin -818.03% -579.43% -209.08% -386.85% 3.99% -5.62% -5.75% -65.3% -679.07% -6.62%
FCF Margin -868.19% -450.46% -188.15% -261.1% -4.32% n/a n/a n/a n/a n/a
EBITDA Margin -877.12% -561.09% -200.17% -382.98% 4.14% -5.61% -5.72% -64.75% -662.03% -6.4%